瑞典终末期肾病患者医疗护理的资金筹集与组织安排
The financing and organization of medical care for patients with end-stage renal disease in Sweden.
作者信息
Wikström Björn, Fored Michael, Eichleay Margaret A, Jacobson Stefan H
机构信息
Renal section, Department of Medicine, University Hospital, Uppsala, Sweden.
出版信息
Int J Health Care Finance Econ. 2007 Dec;7(4):269-81. doi: 10.1007/s10754-007-9014-y.
The total health care expenditure as a percentage of the gross domestic product in Sweden is 9.2%, and health care is funded by global budgets almost entirely through general taxation. The prevalence rate of end-stage renal disease (ESRD) in Sweden is 756 per million. Fifty-two percent of ESRD patients have a functioning transplant. Almost all ESRD treatment facilities are public. Compared with other Dialysis Outcomes and Practice Patterns Study (DOPPS) countries, the salaries for both nephrologists and professional dialysis unit staff are low. Sweden's high cost per ESRD patient, relative to other DOPPS countries, may be a result of expensive and frequent hospitalizations and aggressive anemia treatment strategies.
瑞典的医疗保健总支出占国内生产总值的比例为9.2%，医疗保健几乎完全通过一般税收由全球预算提供资金。瑞典终末期肾病（ESRD）的患病率为每百万人口756例。52%的ESRD患者有功能正常的移植器官。几乎所有的ESRD治疗机构都是公立的。与其他透析结局和实践模式研究（DOPPS）国家相比，肾病科医生和专业透析单位工作人员的工资都很低。相对于其他DOPPS国家，瑞典每名ESRD患者的成本较高，这可能是由于昂贵且频繁的住院治疗以及积极的贫血治疗策略所致。
Zotero 插件